How Organovo, Aspect Biosystems & ROKIT Healthcare Are Leading the Future of Regenerative Medicine with 3D Bioprinting
As of January 2025, several leading companies in the 3D bioprinting industry have made significant strides in both research and clinical applications. Here are some of the latest innovations:
Organovo Holdings Inc.: Organovo has been at the forefront of designing functional human tissues using proprietary three-dimensional bioprinting technology. Their goal is to build living human tissues that...
0 Commentaires
0 Parts
385 Vue
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek